Thanks to those of you who responded to my question on the oral formulation status. The consensus I take from the responses is that I was misunderstanding the process. It sounds like the oral formulation that was in the works for the last year+ was for animal toxicology and bioavailability. This step has been completed, tested, and communicated. So the remaining step to commence is to run the bridging toxicology from animals to humans, and if successful they will formulate the human pill form.
I think I summarized all that correctly. All real posters please feel free to chime in if you disagree. Multi-identities need not respond.